Zobrazeno 1 - 7
of 7
pro vyhledávání: '"Elena Barbuti"'
Publikováno v:
Frontiers in Neurology, Vol 14 (2023)
BackgroundRadiologically isolated syndrome (RIS) describes asymptomatic individuals with incidental radiologic abnormalities suggestive of multiple sclerosis (MS). Much of RIS literature is about adult-onset cases. Treatment of RIS is controversial,
Externí odkaz:
https://doaj.org/article/be13db436f384587af29b26a925479a4
Autor:
Riccardo Nistri, Elena Barbuti, Virginia Rinaldi, Laura Tufano, Valeria Pozzilli, Antonio Ianniello, Fabiana Marinelli, Giovanna De Luca, Luca Prosperini, Valentina Tomassini, Carlo Pozzilli
Publikováno v:
Frontiers in Neurology, Vol 12 (2021)
Objective: To describe a temporal association between COVID-19 vaccine administration and multiple sclerosis (MS) relapses.Methods: This case series study was collected in four MS Centres in Central Italy, using data from 16 MS patients who received
Externí odkaz:
https://doaj.org/article/c6b9c98a74ba40af965135027a6134ff
Autor:
Carlo Pozzilli, Luca Prosperini, Silvia Tommasin, Claudio Gasperini, Elena Barbuti, Laura De Giglio
Publikováno v:
Therapeutic Advances in Neurological Disorders, Vol 14 (2021)
Objective: To evaluate baseline characteristics predictive of improving information processing speed in multiple sclerosis (MS) and the relationship between cognitive and motor response to dalfampridine (DA) treatment. Methods: This is a post hoc ana
Externí odkaz:
https://doaj.org/article/c601eeb3b42944eb80841af6ee74a4c9
Publikováno v:
Current Opinion in Neurology. 36:222-228
Autor:
Maria Petracca, Serena Ruggieri, Elena Barbuti, Antonio Ianniello, Roberta Fantozzi, Giorgia Teresa Maniscalco, Vincenzo Andreone, Doriana Landi, Girolama Alessandra Marfia, Maria Di Gregorio, Rosa Iodice, Leonardo Sinisi, Elisabetta Maida, Rosanna Missione, Cinzia Coppola, Simona Bonavita, Giovanna Borriello, Diego Centonze, Giacomo Lus, Carlo Pozzilli, Elisabetta Signoriello
Cladribine administration has been approved for the treatment of relapsing-remitting multiple sclerosis (MS) in 2017; thus, data on cladribine in a real-world setting are still emerging.We report on cladribine effectiveness, safety profile, and treat
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::7d068bc5be6ed41d91f13454f3edfb54
http://hdl.handle.net/11573/1652789
http://hdl.handle.net/11573/1652789
Autor:
Luca Prosperini, Claudio Gasperini, Carlo Pozzilli, Elena Barbuti, Silvia Tommasin, Laura De Giglio
Publikováno v:
Therapeutic Advances in Neurological Disorders, Vol 14 (2021)
Therapeutic Advances in Neurological Disorders
Therapeutic Advances in Neurological Disorders
Objective: To evaluate baseline characteristics predictive of improving information processing speed in multiple sclerosis (MS) and the relationship between cognitive and motor response to dalfampridine (DA) treatment. Methods: This is a post hoc ana
Autor:
Elena Barbuti, Serena Ruggieri, Giovanna Borriello, Carlo Pozzilli, Riccardo Nistri, Antonio Ianniello
Publikováno v:
Journal of the Neurological Sciences. 429:118113